Carotid artery stenting versus carotid endarterectomy for treatment of asymptomatic carotid disease

Interventional Cardiology Clinics

Volumn 3, Issue 1, 2014, Pages 63-72

  Rogers, R Kevin ^a   Gandhi, Sanjay ^b   Rosenfield, Kenneth ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Asymptomatic carotid artery stenosis; Carotid artery stent; Carotid endarterectomy; Stroke

Indexed keywords

ASYMPTOMATIC DISEASE; BRAIN CIRCULUS ARTERIOSUS; BRAIN ISCHEMIA; BRAIN PERFUSION; CARDIOVASCULAR MORTALITY; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CERTIFICATION; CLINICAL COMPETENCE; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING STENT; EMBOLIC PROTECTION DEVICE; GERIATRIC PATIENT; GUIDE WIRE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LIFE EXPECTANCY; LONGEVITY; MEDICAID; MEDICAL DECISION MAKING; MEDICARE; META ANALYSIS (TOPIC); NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PERSONALIZED MEDICINE; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECERTIFICATION; REIMBURSEMENT; REVASCULARIZATION; REVIEW; RISK REDUCTION; SMOKING; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL RISK; SYSTEMATIC REVIEW (TOPIC); TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 84888389936     PISSN: 22117458     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iccl.2013.09.009     Document Type: Review

References (39)

1. Halliday A., Mansfield A., Marro J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004, 363(9420):1491-1502.
2. Hobson R.W., Weiss D.G., Fields W.S., et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. NEngl J Med 1993, 328(4):221-227.
3. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995, 273(18):1421-1428.
4. Naylor A.R. What is the current status of angioplasty vs endarterectomy in patients with asymptomatic carotid artery disease?. JCardiovasc Surg (Torino) 2007, 48(2):161-180.
5. Ringleb P.A., Allenberg J., Bruckmann H., et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006, 368(9543):1239-1247.
6. Mas J.L., Chatellier G., Beyssen B., et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. NEngl J Med 2006, 355(16):1660-1671.
7. International Carotid Stenting Study, Ederle J., Dobson J., Featherstone R.L., et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet 2010, 375(9719):985-997.
8. Brott T.G., Hobson R.W., Howard G., et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. NEngl J Med 2010, 363(1):11-23.
9. Yadav J.S., Wholey M.H., Kuntz R.E., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. NEngl J Med 2004, 351(15):1493-1501.
10. American College of Cardiology Foundation/American Heart Association Task F, American Stroke A, American Association of Neuroscience N, American Association of Neurological S, American College of R, American Society of N, Brott T.G., Halperin J.L., Abbara S., et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. JNeurointerv Surg 2011, 3(2):100-130.
11. Gurm H.S., Yadav J.S., Fayad P., et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. NEngl J Med 2008, 358(15):1572-1579.
12. Barnett H.J., Taylor D.W., Eliasziw M., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. NEngl J Med 1998, 339(20):1415-1425.
13. Gray W.A., Chaturvedi S., Verta P. Thirty-day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, high-surgical-risk registries. Circ Cardiovasc Interv 2009, 2(3):159-166.
14. Gray W.A., Hopkins L.N., Yadav S., et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. JVasc Surg 2006, 44(2):258-268.
15. Higashida R.T., Popma J.J., Apruzzese P., et al. Evaluation of the Medtronic exponent self-expanding carotid stent system with the Medtronic Guardwire temporary occlusion and aspiration system in the treatment of carotid stenosis: combined from the MAVErIC (Medtronic AVE Self-expanding CaRotid Stent System with distal protection In the treatment of Carotid stenosis) I and MAVErIC II trials. Stroke 2010, 41(2):e102-e109.
16. Hopkins L.N., Myla S., Grube E., et al. Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-year results in the CABERNET trial. Catheter Cardiovasc Interv 2008, 71(7):950-960.
17. Safian R.D., Bresnahan J.F., Jaff M.R., et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. JAm Coll Cardiol 2006, 47(12):2384-2389.
18. White C.J., Iyer S.S., Hopkins L.N., et al. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv 2006, 67(4):503-512.
19. Groeneveld P.W., Epstein A.J., Yang F. Medicare's policy on carotid stents limited use to hospitals meeting quality guidelines yet did not hurt disadvantaged. Health Aff (Millwood) 2010, 30(2):312-321.
20. Safian R.D. Carotid artery stenting: payment, politics, and equipose. JAm Coll Cardiol 2012, 59(15):1390-1391.
21. Endo A. The discovery and development of HMG-CoA reductase inhibitors. JLipid Res 1992, 33(11):1569-1582.
22. Abbott A.L. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009, 40(10):e573-e583.
23. Garg N., Karagiorgos N., Pisimisis G.T., et al. Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: a systematic review of the current literature. JEndovasc Ther 2009, 16(4):412-427.
24. Bersin R.M., Stabile E., Ansel G.M., et al. Ameta-analysis of proximal occlusion device outcomes in carotid artery stenting. Catheter Cardiovasc Interv 2012, 80(7):1072-1078.
25. Stabile E., Salemme L., Sorropago G., et al. Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients. JAm Coll Cardiol 2010, 55(16):1661-1667.
26. Ansel G.M., Hopkins L.N., Jaff M.R., et al. Safety and effectiveness of the INVATEC MO.MA proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial. Catheter Cardiovasc Interv 2010, 76(1):1-8.
27. Nikas D., Reith W., Schmidt A., et al. Prospective, multicenter European study of the GORE flow reversal system for providing neuroprotection during carotid artery stenting. Catheter Cardiovasc Interv 2012, 80(7):1060-1068.
28. Clair D.G., Hopkins L.N., Mehta M., et al. Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Catheter Cardiovasc Interv 2011, 77(3):420-429.
29. Parodi J.C., La Mura R., Ferreira L.M., et al. Initial evaluation of carotid angioplasty and stenting with three different cerebral protection devices. JVasc Surg 2000, 32(6):1127-1136.
30. Bijuklic K., Wandler A., Hazizi F., et al. The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): a prospective randomized trial. JAm Coll Cardiol 2012, 59(15):1383-1389.
31. Holt P.J., Poloniecki J.D., Loftus I.M., et al. Meta-analysis and systematic review of the relationship between hospital volume and outcome following carotid endarterectomy. Eur J Vasc Endovasc Surg 2007, 33(6):645-651.
32. Gray W.A., Rosenfield K.A., Jaff M.R., et al. Influence of site and operator characteristics on carotid artery stent outcomes: analysis of the CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) clinical study. JACC Cardiovasc Interv 2011, 4(2):235-246.
33. Voeks J.H., Howard G., Roubin G.S., et al. Age and outcomes after carotid stenting and endarterectomy: the Carotid Revascularization Endarterectomy versus Stenting trial. Stroke 2011, 42(12):3484-3490.
34. Grant A., White C., Ansel G., et al. Safety and efficacy of carotid stenting in the very elderly. Catheter Cardiovasc Interv 2010, 75(5):651-655.
35. Setacci C., de Donato G., Chisci E., et al. Is carotid artery stenting in octogenarians really dangerous?. JEndovasc Ther 2006, 13(3):302-309.
36. Cohen D.J., Stolker J.M., Wang K., et al. Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). JAm Coll Cardiol 2011, 58(15):1557-1565.
37. Blackshear J.L., Cutlip D.E., Roubin G.S., et al. Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation 2011, 123(22):2571-2578.
38. Coppi G., Moratto R., Silingardi R., et al. PRIAMUS-proximal flow blockage cerebral protection during carotid stenting: results from a multicenter Italian registry. JCardiovasc Surg (Torino) 2005, 46(3):219-227.
39. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001, 357(9270):1729-1737.